Armen Shanafelt's Net Worth
$42.9 Million
Who is Armen Shanafelt?
Armen Shanafelt has an estimated net worth of $42.9 Million. This is based on reported shares across multiple companies, which include Protagonist Therapeutics, Inc, Surface Oncology, Inc., Aeglea BioTherapeutics, Inc., and AILERON THERAPEUTICS INC.
SEC CIK
Armen Shanafelt's CIK is 0001656151
Past Insider Trading and Trends
2016 was Armen Shanafelt's most active year for acquiring shares with 7 total transactions. Armen Shanafelt's most active month to acquire stocks was the month of May. 2017 was Armen Shanafelt's most active year for disposing of shares, totalling 4 transactions. Armen Shanafelt's most active month to dispose stocks was the month of June. 2016 saw Armen Shanafelt paying a total of $6,999,996.00 for 4,158,406 shares, this is the most they've acquired in one year. In 2016 Armen Shanafelt cashed out on 21,984,190 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aeglea BioTherapeutics, Inc. (AGLE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 150K |
$3.66 | $549,692.38 | 150K |
Dec 9 - Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4/A
| +3,490.04% | 2.01M |
—
|
—
| 2.07M |
Apr 12
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $25.46
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 4
|
∞
| 2.1M |
$12.00 |
—
| 2.1M |
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surface Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
∞
| 3.45M |
$15.00 |
—
| 3.45M |
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AILERON THERAPEUTICS INC (ALRN) Snapshot price: $4.34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
|
∞
| 1.09M |
$15.00 |
—
| 1.09M |
Jul 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||